Skip to main content
graph.swiss
Medacta Group SA

Medacta Group SA

138.20 CHF-1.60 (-1.14%)
XSWX:MOVEMarket Closed
ListedCHF2.8BHealthcareMedical Devices2,036 employees

Company Profile

Legal NameMedacta Group SA
CEOMr. Ahmed Khaled El-Hoshy
HeadquartersStrada Regina, 34
Phone41 91 696 60 60
Employees (FTE)2,036
SectorHealthcare
IndustryMedical Devices

Business Description

Medacta Group SA is a Swiss-based medical device company specializing in the development, manufacturing, and distribution of orthopedic and neurosurgical products. Founded in 1999 by Dr. Alberto Siccardi, an orthopedic patient, it is headquartered in Castel San Pietro, Switzerland, and operates in over 60 countries across Europe, North America, Asia-Pacific, Latin America, and the Middle East and Africa. The company offers innovative solutions for joint replacement surgeries including hip, knee, and shoulder systems, as well as spine surgery, sports medicine, and revision procedures. Notable features include personalized 3D planning tools like MySolutions, patient-matched technologies such as MyKnee and MyHip, and advanced materials like HighCross and 3D Metal, emphasizing minimally invasive techniques and kinematic alignment for improved patient outcomes. Medacta Group SA supports surgeons through its global M.O.R.E. Institute for medical education and focuses on sustainable innovation. With approximately 1,907 employees, it generates significant revenue from medical products, playing a key role in the healthcare equipment sector by advancing personalized and efficient surgical solutions worldwide.

Profitability & Growth

Profitability

Profit Margin+13.96%
Operating Margin+15.96%
Return on Equity (TTM)+22.83%
Return on Assets (TTM)+8.39%

Recent Year-End

Revenue632.3M
Revenue / Share34.32
Gross Profit424.1M
EBITDA180.3M
Diluted EPS4.40
Earnings Growth YoY+1.50%
Revenue Growth YoY+12.50%

Balance Sheet Snapshot

Total Cash (MRQ)

30.7M

Total Debt (MRQ)

242.9M

Current Ratio (MRQ)

2.08

Book Value / Share

21.15

Stock Statistics

Shares Outstanding19.9M
Float Shares6.0M
Avg Volume (10d)26.9K
Avg Volume (90d)22.4K
% Held by Insiders+69.66%
% Held by Institutions+15.20%

Valuation

Market Cap2.75B
Enterprise Value2.75B
Trailing P/E31.36
Forward P/E24.98
PEG Ratio24.98
Price / Sales (TTM)4.02
Price / Book (MRQ)6.52
EV / Revenue4.35
EV / EBITDA17.32

Price Summary

52-Week Low128.60
52-Week High177.20
50-Day MA137.91
200-Day MA149.94
Beta0.99

Dividends

Forward Div Rate4.40
Forward Div Yield+3.20%
Trailing Div Rate1.10
Payout Ratio+15.48%
Dividend Date2025-05-13
Ex-Dividend Date2026-05-07